We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Glioblastoma survival in the United States improved after Food and Drug Administration approval of bevacizumab: a population-based analysis.
- Authors
Johnson, Derek R; Leeper, Heather E; Uhm, Joon H
- Abstract
Bevacizumab received US Food and Drug Administration approval for use in recurrent glioblastoma based on promising radiographic response data, but without clear evidence that it prolongs survival. A population-based analysis was conducted to determine whether bevacizumab approval was associated with improved glioblastoma survival in the United States.
- Publication
Cancer, 2013, Vol 119, Issue 19, p3489
- ISSN
1097-0142
- Publication type
Journal Article
- DOI
10.1002/cncr.28259